Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2025-08-14

SEC-registered investment adviser since 2017 · limited partnership

$992.2m reported value +12.3% vs Q1 2025
67positions
53.3%in top 10
19 new 22 added 21 reduced 7 sold out vs Q1 2025

Options: 0 call positions (— notional), 1 put positions ($95.0m notional) – listed below, not included above.

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NATERA INC COM NTRA NTRA 796,375 $134.5m13.56% 13.56% ReducedShares held: Q3 2024 870.2k, Q4 2024 876.8k, Q1 2025 893.7k, Q2 2025 796.4k -97.3k -97,346 -10.9%
2 GSK PLC SPONSORED ADR GSK GSK 2,242,388 $86.1m8.68% 8.68% ReducedShares held: Q3 2024 4.1m, Q4 2024 3.7m, Q1 2025 2.6m, Q2 2025 2.2m -380.9k -380,858 -14.5%
3 VERA THERAPEUTICS INC CL A VERA VERA 2,383,055 $56.1m5.66% 5.66% AddedShares held: Q3 2024 2.1m, Q4 2024 1.6m, Q1 2025 1.9m, Q2 2025 2.4m +484.3k +484,251 25.5%
4 REVVITY INC COM RVTY RVTY 510,330 $49.4m4.97% 4.97% AddedShares held: Q3 2024 469.7k, Q4 2024 392.5k, Q1 2025 299.1k, Q2 2025 510.3k +211.2k +211,243 70.6%
5 VAXCYTE INC COM PCVX PCVX 1,298,514 $42.2m4.25% 4.25% AddedShares held: Q3 2024 0, Q4 2024 127.6k, Q1 2025 557.1k, Q2 2025 1.3m +741.4k +741,444 133.1%
6 HCA HEALTHCARE INC COM HCA HCA 99,983 $38.3m3.86% 3.86% ReducedShares held: Q3 2024 129.1k, Q4 2024 175.8k, Q1 2025 152.5k, Q2 2025 100.0k -52.5k -52,519 -34.4%
7 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 4,065,355 $38.1m3.84% 3.84% ReducedShares held: Q3 2024 4.1m, Q4 2024 343.4k, Q1 2025 4.2m, Q2 2025 4.1m -146.9k -146,915 -3.5%
8 BRUKER CORP COM BRKR BRKR 839,284 $34.6m3.48% 3.48% AddedShares held: Q3 2024 0, Q4 2024 234.9k, Q1 2025 499.2k, Q2 2025 839.3k +340.1k +340,077 68.1%
9 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,902,539 $26.6m2.68% 2.68% AddedShares held: Q3 2024 691.2k, Q4 2024 780.0k, Q1 2025 1.4m, Q2 2025 1.9m +524.9k +524,865 38.1%
10 IONIS PHARMACEUTICALS INC COM IONS IONS 588,900 $23.3m2.34% 2.34% AddedShares held: Q3 2024 471.4k, Q4 2024 215.0k, Q1 2025 517.0k, Q2 2025 588.9k +71.9k +71,879 13.9%
11 CENTENE CORP DEL COM CNC CNC 398,726 $21.6m2.18% 2.18% AddedShares held: Q3 2024 135.0k, Q4 2024 188.5k, Q1 2025 340.3k, Q2 2025 398.7k +58.4k +58,387 17.2%
12 INSPIRE MED SYS INC COM INSP INSP 164,473 $21.3m2.15% 2.15% ReducedShares held: Q3 2024 276.3k, Q4 2024 294.3k, Q1 2025 186.4k, Q2 2025 164.5k -22.0k -21,952 -11.8%
13 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 6,144,384 $20.9m2.11% 2.11% ReducedShares held: Q3 2024 8.8m, Q4 2024 2.8m, Q1 2025 8.5m, Q2 2025 6.1m -2.3m -2,313,636 -27.4%
14 AVANTOR INC COM AVTR AVTR 1,526,164 $20.5m2.07% 2.07% AddedShares held: Q3 2024 168.4k, Q4 2024 168.4k, Q1 2025 122.8k, Q2 2025 1.5m +1.4m +1,403,341 1142.6%
15 BIO-TECHNE CORP COM TECH TECH 394,139 $20.3m2.04% 2.04% AddedShares held: Q3 2024 663.6k, Q4 2024 299.3k, Q1 2025 280.1k, Q2 2025 394.1k +114.0k +114,022 40.7%
16 TRAVERE THERAPEUTICS INC COM TVTX TVTX 1,315,033 $19.5m1.96% 1.96% AddedShares held: Q3 2024 869.9k, Q4 2024 490.3k, Q1 2025 816.3k, Q2 2025 1.3m +498.8k +498,779 61.1%
17 ZIMVIE INC COM ZIMV ZIMV 2,079,380 $19.4m1.96% 1.96% UnchangedShares held: Q3 2024 2.1m, Q4 2024 2.1m, Q1 2025 2.1m, Q2 2025 2.1m
18 UNITEDHEALTH GROUP INC COM UNH UNH 60,736 $18.9m1.91% 1.91% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 60.7k
19 ILLUMINA INC COM ILMN ILMN 198,584 $18.9m1.91% 1.91% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 198.6k
20 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 1,052,881 $17.6m1.78% 1.78% ReducedShares held: Q3 2024 3.2m, Q4 2024 2.2m, Q1 2025 1.4m, Q2 2025 1.1m -357.9k -357,884 -25.4%
21 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 838,736 $17.1m1.72% 1.72% AddedShares held: Q3 2024 564.9k, Q4 2024 719.8k, Q1 2025 696.5k, Q2 2025 838.7k +142.2k +142,237 20.4%
22 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 59,366 $17.1m1.72% 1.72% AddedShares held: Q3 2024 130.9k, Q4 2024 43.7k, Q1 2025 57.5k, Q2 2025 59.4k +1.9k +1,877 3.3%
23 HEALTHEQUITY INC COM HQY HQY 155,868 $16.3m1.65% 1.65% ReducedShares held: Q3 2024 319.1k, Q4 2024 386.7k, Q1 2025 352.0k, Q2 2025 155.9k -196.1k -196,108 -55.7%
24 IQVIA HLDGS INC COM IQV IQV 97,604 $15.4m1.55% 1.55% NewShares held: Q3 2024 13.1k, Q4 2024 0, Q1 2025 0, Q2 2025 97.6k
25 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 277,316 $15.3m1.54% 1.54% ReducedShares held: Q3 2024 445.2k, Q4 2024 678.8k, Q1 2025 547.1k, Q2 2025 277.3k -269.8k -269,800 -49.3%
26 DYNAVAX TECHNOLOGIES CORP COM NEW DVAX DVAX 1,197,189 $11.9m1.20% 1.20% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 1.2m
27 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 232,175 $11.8m1.19% 1.19% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 232.2k
28 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 1,207,638 $10.8m1.09% 1.09% ReducedShares held: Q3 2024 535.4k, Q4 2024 2.0m, Q1 2025 2.2m, Q2 2025 1.2m -964.8k -964,798 -44.4%
29 EVOLUS INC COM EOLS EOLS 1,170,311 $10.8m1.09% 1.09% NewShares held: Q3 2024 453.1k, Q4 2024 383.0k, Q1 2025 0, Q2 2025 1.2m
30 HUMANA INC COM HUM HUM 43,620 $10.7m1.07% 1.07% AddedShares held: Q3 2024 33.9k, Q4 2024 22.7k, Q1 2025 28.0k, Q2 2025 43.6k +15.7k +15,650 56.0%
31 GERON CORP COM GERN GERN 7,320,174 $10.3m1.04% 1.04% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 7.3m
32 GLOBUS MED INC CL A GMED GMED 169,643 $10.0m1.01% 1.01% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 192.9k, Q2 2025 169.6k -23.2k -23,250 -12.1%
33 ICON PLC SHS ICLR ICLR 64,587 $9.4m0.95% 0.95% AddedShares held: Q3 2024 13.7k, Q4 2024 19.3k, Q1 2025 10.8k, Q2 2025 64.6k +53.7k +53,747 495.8%
34 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 414,430 $7.5m0.76% 0.76% AddedShares held: Q3 2024 307.4k, Q4 2024 275.4k, Q1 2025 281.0k, Q2 2025 414.4k +133.5k +133,479 47.5%
35 ELEVANCE HEALTH INC COM ELV ELV 18,962 $7.4m0.74% 0.74% AddedShares held: Q3 2024 19.5k, Q4 2024 29.2k, Q1 2025 15.7k, Q2 2025 19.0k +3.3k +3,264 20.8%
36 REGENERON PHARMACEUTICALS COM REGN REGN 13,254 $7.0m0.70% 0.70% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 13.3k
37 MERUS N V COM MRUS MRUS 130,924 $6.9m0.69% 0.69% AddedShares held: Q3 2024 68.3k, Q4 2024 68.3k, Q1 2025 70.3k, Q2 2025 130.9k +60.6k +60,595 86.2%
38 MOLINA HEALTHCARE INC COM MOH MOH 20,600 $6.1m0.62% 0.62% ReducedShares held: Q3 2024 10.6k, Q4 2024 0, Q1 2025 23.7k, Q2 2025 20.6k -3.1k -3,135 -13.2%
39 THERMO FISHER SCIENTIFIC INC COM TMO TMO 13,685 $5.5m0.56% 0.56% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 13.7k
40 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 392,739 $5.1m0.52% 0.52% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 392.7k
41 DANAHER CORPORATION COM DHR DHR 23,449 $4.6m0.47% 0.47% NewShares held: Q3 2024 38.4k, Q4 2024 22.2k, Q1 2025 0, Q2 2025 23.4k
42 LIQUIDIA CORPORATION COM NEW LQDA LQDA 358,828 $4.5m0.45% 0.45% AddedShares held: Q3 2024 137.9k, Q4 2024 571.3k, Q1 2025 150.5k, Q2 2025 358.8k +208.3k +208,348 138.5%
43 GLAUKOS CORP COM GKOS GKOS 31,496 $3.3m0.33% 0.33% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 159.0k, Q2 2025 31.5k -127.5k -127,461 -80.2%
44 ZENAS BIOPHARMA INC COM ZBIO ZBIO 325,479 $3.2m0.32% 0.32% ReducedShares held: Q3 2024 190.5k, Q4 2024 172.1k, Q1 2025 445.6k, Q2 2025 325.5k -120.1k -120,109 -27.0%
45 NEKTAR THERAPEUTICS COM NEW NKTR NKTR 115,000 $3.0m0.30% 0.30% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 115.0k
46 ALECTOR INC COM ALEC ALEC 1,986,072 $2.8m0.28% 0.28% AddedShares held: Q3 2024 332.8k, Q4 2024 200.1k, Q1 2025 617.4k, Q2 2025 2.0m +1.4m +1,368,654 221.7%
47 AMARIN CORP PLC SPONSORED ADR AMRN AMRN 167,276 $2.7m0.27% 0.27% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 167.3k
48 MANNKIND CORP COM NEW MNKD MNKD 697,710 $2.6m0.26% 0.26% UnchangedShares held: Q3 2024 2.0m, Q4 2024 911.0k, Q1 2025 697.7k, Q2 2025 697.7k
49 89BIO INC COM ETNB ETNB 235,990 $2.3m0.23% 0.23% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 303.7k, Q2 2025 236.0k -67.7k -67,741 -22.3%
50 REPLIGEN CORP COM RGEN RGEN 18,620 $2.3m0.23% 0.23% AddedShares held: Q3 2024 163.6k, Q4 2024 54.1k, Q1 2025 18.5k, Q2 2025 18.6k +168 +168 0.9%
51 GOSSAMER BIO INC COM GOSS GOSS 1,695,762 $2.1m0.21% 0.21% ReducedShares held: Q3 2024 5.0m, Q4 2024 5.0m, Q1 2025 3.9m, Q2 2025 1.7m -2.2m -2,201,079 -56.5%
52 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 99,338 $2.1m0.21% 0.21% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 99.3k
53 RELAY THERAPEUTICS INC COM RLAY RLAY 533,409 $1.8m0.19% 0.19% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 533.4k
54 SUTRO BIOPHARMA INC COM COM 2,292,261 $1.6m0.16% 0.16% UnchangedShares held: Q3 2024 1.8m, Q4 2024 694.4k, Q1 2025 2.3m, Q2 2025 2.3m
55 MARAVAI LIFESCIENCES HLDGS I COM CL A MRVI MRVI 640,673 $1.5m0.16% 0.16% ReducedShares held: Q3 2024 337.0k, Q4 2024 0, Q1 2025 942.5k, Q2 2025 640.7k -301.8k -301,781 -32.0%
56 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 211,469 $1.5m0.15% 0.15% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 211.5k
57 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 610,231 $1.4m0.14% 0.14% AddedShares held: Q3 2024 406.6k, Q4 2024 98.9k, Q1 2025 343.9k, Q2 2025 610.2k +266.3k +266,284 77.4%
58 INFLARX NV COM IFRX IFRX 1,640,430 $1.3m0.13% 0.13% ReducedShares held: Q3 2024 1.6m, Q4 2024 492.5k, Q1 2025 1.7m, Q2 2025 1.6m -35.5k -35,548 -2.1%
59 PENNANT GROUP INC COM PNTG PNTG 37,980 $1.1m0.11% 0.11% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 38.0k
60 KARYOPHARM THERAPEUTICS INC COM NEW KPTI KPTI 257,154 $1.1m0.11% 0.11% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 257.2k, Q2 2025 257.2k
61 ITEOS THERAPEUTICS INC COM ITOS ITOS 109,324 $1.1m0.11% 0.11% ReducedShares held: Q3 2024 0, Q4 2024 220.2k, Q1 2025 220.2k, Q2 2025 109.3k -110.9k -110,872 -50.4%
62 FORTREA HLDGS INC COMMON STOCK FTRE FTRE 219,384 $1.1m0.11% 0.11% ReducedShares held: Q3 2024 458.0k, Q4 2024 401.7k, Q1 2025 293.3k, Q2 2025 219.4k -73.9k -73,891 -25.2%
63 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 240,688 $825.6k0.08% 0.08% ReducedShares held: Q3 2024 1.3m, Q4 2024 996.1k, Q1 2025 275.8k, Q2 2025 240.7k -35.1k -35,100 -12.7%
64 ARCTURUS THERAPEUTICS HLDGS COM ARCT ARCT 48,364 $629.2k0.06% 0.06% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 48.4k
65 EHEALTH INC COM EHTH EHTH 128,322 $558.2k0.06% 0.06% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 89.2k, Q2 2025 128.3k +39.1k +39,102 43.8%
66 MODIVCARE INC COM MODVQ MODVQ 100,000 $312.0k0.03% 0.03% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 100.0k
67 AC IMMUNE SA SHS ACIU ACIU 100,752 $204.5k0.02% 0.02% UnchangedShares held: Q3 2024 99.3k, Q4 2024 0, Q1 2025 100.8k, Q2 2025 100.8k

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
NEUROCRINE BIOSCIENCES INC NBIX NBIX 167,243 $18.5m167.2k shares
INVESCO QQQ TR QQQ QQQ 24,003 $11.3m24.0k shares
ALIGN TECHNOLOGY INC ALGN ALGN 49,277 $7.8m49.3k shares
TELEFLEX INCORPORATED TFX TFX 56,630 $7.8m56.6k shares
NOVAVAX INC NVAX NVAX 365,523 $2.3m365.5k shares
AMARIN CORP PLC 3,399,204 $1.5m3.4m shares
XOMA ROYALTY CORPORATION XOMA XOMA 45,017 $897.2k45.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
INVESCO QQQ TR QQQ · Put QQQPut 172,200 $95.0m172.2k shares Added

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17